Stay updated on Sitravatinib for Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib for Metastatic Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The changes are cosmetic UI/layout adjustments and minor wording changes; core trial details such as eligibility criteria, outcomes, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:24:02.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-05T10:15:54.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:18:58.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page is updated to Revision: v3.0.2, replacing v3.0.1; the 'Back to Top' link was removed.
    Difference
    0.3%
    Check dated 2025-09-13T17:41:57.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-09-06T15:25:25.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, while also removing specific location terms and previous version information. Additionally, it now includes references to sitravatinib and Skin and Connective Tissue Diseases.
    Difference
    1%
    Check dated 2025-08-30T12:11:03.000Z thumbnail image

Stay in the know with updates to Sitravatinib for Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.